The tumorigenic properties of topical methoxsalen (8-MOP) and trioxsalen (TMP) plus ultraviolet light A (UVA) were studied in NMRI female mice. The animals were treated three times weekly for 9 months, and followed up for 18 months. Acetonic solutions of TMP (0.1 mg in 0.2 ml) and 8-MOP (0.6 mg in 0.2 ml) were applied to the shaved back skin of the mice and irradiated with UVA. The doses needed to elicit equivalent phototoxic effects were 0.29 J/cm2 in the TMP group and 1.09 J/cm2 in the 8-MOP group. Papillomas, keratoacanthomas, and squamous cell carcinomas developed in the 8-MOP group only, and the first tumor was seen at 10 months after the beginning of the study. The results suggest that the carcinogenicity of these two modes of photochemotherapy may differ.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Berne B, Fischer T, Michaëlsson G, Norén P (1984) Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients. Photodermatology 1:18–22
Fitzpatrick TB, Arndt KA, ElMofty AM, Pathak MA (1966) Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo. Arch Dermatol 93:589–599
Frej JV, Stephens P (1968) The correlation of promotion of tumor growth and of induction of hyperplasia in epidermal two-stage carcinogenesis. Br J Cancer 22:83–92
Griffin AC, Hakim RE, Knox J (1958) The wave length effect upon erythemal and carcinogenic response in psoralen treated mice. J Invest Dermatol 31:289–295
Hakim RE, Griffin AC, Knox JM (1960) Erythema and tumor formation in methoxsalen-treated mice exposed to fluorescent light. Arch Dermatol 82:572–577
Hannuksela M, Karvonen J (1984) Topical trioxsalen PUVA therapy. Acta Dermatol Venereol (Stockh) 113:135–138
Hecker E, Kubinyi H (1965) Über die Wirkstoffe des Crotonöls. IV. Reindarstellung und Charakterisierung der entzündlichen und cocarcinogenen Wirkstoffe B1 und B2. Z Krebsforsch 67:176–191
Kirkland DJ, Creed KL, Mannisto P (1983) Comparative bacterial mutagenicity studies with 8-methoxypsoralen and 4,5′,8-trimethylpsoralen in the presence of near-ultraviolet light and in the dark. Mutat Res 116:73–82
Koulu LM, Jansén CT (1984) Skin phototoxicity variations during repeated bath PUVA exposures to 8-methoxypsoralen and trimethylpsoralen. Clin Exp Dermatol 9:64–69
Langner A, Wolska H, Marzulli FN, Jablonski S, Jarzabek-Chorzelska M, Glinski W, Pawinska M (1977) Dermal toxicity of 8-methoxypsoralen administered (by gavage) to hairless mice irradiated with long-wave ultraviolet light. J Invest Dermatol 69:451–457
Mandula BB, Pathak MA, Dudek G (1976) Photochemotherapy: Identification of a metabolite of 4,5′,8-trimethylpsoralen. Science 193:1131–1134
Mandula BB, Pathak MA, Nakayama Y, Davidson SJ (1978) Induction of mixed-function oxidases in mouse liver by psoralens. Br J Dermatol 99:687–692
O'Neal MA, Griffin AC (1957) The effect of oxypsoralen upon ultraviolet carcinogenesis in albino mice. Cancer Res 17:911–916
Pathak MA, Marciani MS, Guiotto A, Rodighiero G (1983) A study of the relationship between photosensitizing and therapeutic activity of 4,5′,8-trimethylpsoralen, and its major metabolite 4,8-dimethyl,5′-carboxypsoralen. J Invest Dermatol 81:533–539
Quinto I, Averbeck D, Moustacchi E, Hrisoho Z, Moron J (1984) Frameshift mutagenicity in Salmonella typhimurium of furocoumarins in the dark. Mutat Res 136:49–54
Salo OP, Lassus A, Taskinen J (1981) Trioxsalen bath plus UVA treatment of psoriasis. Acta Dermatol Venereol (Stockh) 61:551–554
Stenbäck F (1982) Health hazards from ultraviolet radiation. Public Health Reviews. Int Q 10:229–337
Stenbäck F, Garcia H, Shubik P (1974) The present status of the concept of promotion and cocarcinogenesis in the skin. In: Hombrugger F (ed) Physiopathology of cancer. Karger, Basel
Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL (1984) Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 310:1156–1161
Urbach F (1959) Modification of ultraviolet carcinogenesis by photoactive agents. J Invest Dermatol 32:373–378
Väätäinen N, Hannuksela M, Karvonen J (1981) Long-term local trioxsalen photochemotherapy in psoriasis. Dermatologica 163:229–321
Yarosh DB, Johns V, Mufti S, Bernstein C, Bernstein H (1980) Inhibition of UV and psoralen-plus-light mutagenesis in phage T4 by gene 43 antimutator polymerase alleles. Photochem Photobiol 31:341–350
Yoon K (1982) Localized mutagenesis of the tetracycline promoter region in pBR322 by 4,5′,8-trimethylpsoralen. Mutat Res 93:253–262
Young AR, Magnus IA, Davies AC, Smith NP (1983) A comparison of the phototumorigenic potential of 8-MOP and 5-MOP in hairless albino mice exposed to solar simulated radiation. Br J Dermatol 108:507–518
About this article
Cite this article
Hannuksela, M., Stenbäck, F. & Lahti, A. The carcinogenic properties of topical PUVA. Arch Dermatol Res 278, 347–351 (1986). https://doi.org/10.1007/BF00418161
- Skin cancers
- Carcinogenesis, experimental